Abstract
We propose developing and validating a three-dimensional (3D) deep learningsystem using the entire unprocessed OCT optic nerve volumes to distinguish trueglaucoma from normals in order to discover any additional imaging biomarkerswithin the cube through saliency mapping. The algorithm has been validatedagainst 4 additional distinct datasets from different countries usingmultimodal test results to define glaucoma rather than just the OCT alone. 2076 OCT (Cirrus SD-OCT, Carl Zeiss Meditec, Dublin, CA) cube scans centeredover the optic nerve, of 879 eyes (390 healthy and 489 glaucoma) from 487patients, age 18-84 years, were exported from the Glaucoma Clinic ImagingDatabase at the Byers Eye Institute, Stanford University, from March 2010 toDecember 2017. A 3D deep neural network was trained and tested on this uniqueOCT optic nerve head dataset from Stanford. A total of 3620 scans (all obtainedusing the Cirrus SD-OCT device) from 1458 eyes obtained from 4 differentinstitutions, from United States (943 scans), Hong Kong (1625 scans), India(672 scans), and Nepal (380 scans) were used for external evaluation. The 3D deep learning system achieved an area under the receiver operationcharacteristics curve (AUROC) of 0.8883 in the primary Stanford test setidentifying true normal from true glaucoma. The system obtained AUROCs of0.8571, 0.7695, 0.8706, and 0.7965 on OCT cubes from United States, Hong Kong,India, and Nepal, respectively. We also analyzed the performance of the model separately for each myopiaseverity level as defined by spherical equivalent and the model was able toachieve F1 scores of 0.9673, 0.9491, and 0.8528 on severe, moderate, and mildmyopia cases, respectively. Saliency map visualizations highlighted asignificant association between the optic nerve lamina cribrosa region in theglaucoma group.